Icoria to Focus on Healthcare Biotechnology

March 24, 2005

Biotechnology company Icoria, announced that it is transitioning from agricultural R&D activities to concentrate on an aggressive program to discover and validate targets and potential drug candidates for the treatment of diabetes, obesity and liver injury. The company will leverage its metabolomics expertise, gene expression profiling proficiency, quantitative tissue analytics software and proprietary computational capabilities to focus on biomarker-enabled drug discovery.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19483920&full=1)